Patents by Inventor William John Martin

William John Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110306077
    Abstract: Ultraviolet light reactive alternative cellular energy pigments (ACE-pigments) are produced in response to certain chronic viral infections, metabolic disorders and degenerative illnesses. The pigments will display differing responsiveness to direct ultraviolet (UV) light illumination in the presence and in the absence of certain triggering dyes, including neutral red. The type of response appears to reflect varying energy levels of the ACE pigments from being essentially uncharged (fluorescent but only if triggering dye is added); to partially charged (fluorescent even in the absence of a triggering dye) to more fully charged (non-fluorescent either in the presence or absence of the triggering dye). Methods are described for assessing the status of ACE pigments within localized skin and deeper lesions, and within the overall body of a human or animal subject.
    Type: Application
    Filed: June 13, 2010
    Publication date: December 15, 2011
    Inventor: William John Martin
  • Publication number: 20110306917
    Abstract: Alternative cellular energy pigments (ACE-pigments) provide a source of cellular energy other than that provided through the oxidative metabolism of foods, or in the case of plants and certain bacteria, through the process of photosynthesis. In some patients, ACE pigments exist in a form that can be further energized or activated using ultraviolet (UV) light, especially if the reaction is initially triggered by the presence of suitable dyes, such as neutral red. An alternative method has been described to activate the ACE pathway in humans and animals deprived of ACE by using natural or man-made sources of ACE products (enerceuticals), with or without the inclusion of a suitable dye, such as neutral red; and applying the material(s) to the skin, either directly or separated by an impermeable barrier; and illuminating the enerceutical with a UV light source. The process of activating the ACE pathway is evidenced by UV inducible fluorescence seen within areas of the patients' skin and/or mucus membranes.
    Type: Application
    Filed: June 9, 2010
    Publication date: December 15, 2011
    Inventor: William John Martin
  • Publication number: 20110208110
    Abstract: A convenient method for activating the alternative cellular energy (ACE) pathway is described that uses ultraviolet (UV) light illumination of oil extracted from the leaves of the moringa oleifera tree. The moringa leaf oil acts as an “enerceutical,” a term defined by the inventor. The green colored moringa leaf oil can be either applied directly to areas of the skin or placed onto an impermeable barrier that is laid onto the skin. The oil displays a red fluorescence when illuminated by either mercury vapor UV emitting lamps, or bright sunlight. Smearing of the moringa leaf oil over wide surface areas of the skin in conjunction with UV illumination can be used for systemic activation of the ACE pathway. Evidence for successful systemic activation of the ACE pathway includes the appearance of direct UV light inducible tissue and body fluid fluorescence at sites other than where the oil has been applied.
    Type: Application
    Filed: February 24, 2010
    Publication date: August 25, 2011
    Inventor: William John Martin
  • Publication number: 20100291000
    Abstract: Alternative cellular energy pigments (ACE-pigments) provide a source of cellular energy other than that provided through the oxidative metabolism of foods, or in the case of plants and certain bacteria, through the process of photosynthesis. In some patients, ACE pigments exist in a form that can be further energized or activated using ultraviolet (UV) light, especially if the reaction is initially triggered by the presence of suitable dyes, such as neutral red. Once partially activated, ACE pigments within a localized lesion will fluoresce upon direct exposure to UV light. It is diagnostically useful to screen an individual or animal undergoing localized or systemic activation of their ACE pathway for the presence of lesions elsewhere in the body, which become fluorescent under direct UV illumination, both as a way of detecting an otherwise non-apparent or unnoticed lesion and of confirming that such a lesion contains ACE pigments that can be further activated.
    Type: Application
    Filed: July 26, 2010
    Publication date: November 18, 2010
    Inventor: William John Martin
  • Publication number: 20100215763
    Abstract: Alternative cellular energy pigments (ACE-pigments) are over-produced in response to various types of viral infections and to other pathological conditions. ACE pigments accumulate at the sites of disease and also in other regions of the body, including the oral cavity. ACE pigments are considered to play a significant role in the body's healing response to both local and system diseases. They appear to exist in a relatively inactive form in which they can fluorescence under ultraviolet (UV) light illumination, especially if stained with a suitable dye, such as neutral red. The present invention describes a method of using ACE pigments collected from the saliva (spittle) of patients for the purpose of activating the ACE pathway in a child with autism and in an adult with an active skin lesion caused by herpes simplex virus. The saliva containing the collected ACE pigments is placed onto a suitable material, such as a paper towel, stained with neutral red dye and induced to fluoresce using UV illumination.
    Type: Application
    Filed: February 20, 2009
    Publication date: August 26, 2010
    Inventor: William John Martin
  • Publication number: 20100196297
    Abstract: Alternative cellular energy pigments (ACE-pigments) are over-produced in response to various types of viral infections and to other pathological conditions. ACE pigments accumulate at the sites of disease and also in other regions of the body, including the oral cavity. ACE pigments are considered to play a significant role in the body's healing response to both local and system diseases. They appear to exist in a relatively inactive form in which they can fluorescence under ultraviolet (UV) light illumination, especially if stained with a suitable dye, such as neutral red. The present invention describes a method of using ACE pigments collected from the urine of patients for the purpose of activating the patient's ACE pathway in a child with autism, with an extrapolation to patients with a wide variety of other infectious and non-infectious illnesses for which there is a presumed or shown insufficiency of cellular energy.
    Type: Application
    Filed: March 5, 2009
    Publication date: August 5, 2010
    Inventor: William John Martin
  • Publication number: 20100099758
    Abstract: A composition containing copper and silver ions electrolytically generated in a solution of citric acid that also contains potassium carbonate is shown to expedite the healing of wounds with regeneration of normal tissue architecture and without excessive scarring. A wide range of wounds and other forms of tissue damage affecting the skin and other areas of the body respond favorably to the direct application of the composition, with expedited healing, re-growth of normal appearing (non-scar) tissue and symptomatic relief from pain and swelling. The composition acts in both humans and animals through a novel mechanism provisionally termed the tissue regeneration induced pathway (TRIP).
    Type: Application
    Filed: October 22, 2008
    Publication date: April 22, 2010
    Applicant: MI Hope Inc.
    Inventors: William John Martin, Stephen Benet Palmer
  • Publication number: 20100011657
    Abstract: The combustion of gasoline can be facilitated by the addition of molecular hydrogen. The hydrogen can be generated by placing into the gasoline a hydrogen generating device, such as a mixture of metallic magnesium and EH-101 (HB-101) containing solution, whereby the device allows for the selective passage of the generated hydrogen but restricts the passage of magnesium and EH-101 (HB-101) components. This partitioning of hydrogen from EH-101 (HB-101) components is achieved by using reverse osmosis membrane, low density gasoline resistant plastic material or low molecular weight cutoff dialysis membrane to create a sealed container of the magnesium and EH-101 (HB-101) components, which can be placed into the gasoline. The EH-101 (HB-101) can be initially placed into a breakable inner compartment within the hydrogen permeable container. This compartment can be easily broken by simple squeezing just prior to placing the device into the gasoline that is intended to have its hydrogen content increased.
    Type: Application
    Filed: July 18, 2008
    Publication date: January 21, 2010
    Inventor: William John Martin
  • Publication number: 20100008850
    Abstract: Consuming water with increased hydrogen content can provide clinical benefits to humans and animals through a non-mitochondria alternative cellular energy (ACE) pathway and also as an antioxidant. This application discloses that the hydrogen content of drinking water can be safely increased by placing into the water a hydrogen generating device, such as a mixture of metallic magnesium and EH-101 (HB-101) containing solution, whereby the device allows for the selective passage of the generated hydrogen but restricts the passage of magnesium and EH-101 (HB-101) components. This partitioning of hydrogen from EH-101 (HB-101) components is achieved by using either reverse osmosis membrane, low density plastic material such as polyvinylidene chloride (PVDC or Saran), or low molecular weight cutoff dialysis membrane to create a sealed container of the magnesium and magnesium chloride, that can be placed into drinkable water.
    Type: Application
    Filed: July 14, 2008
    Publication date: January 14, 2010
    Inventor: William John Martin
  • Publication number: 20100008849
    Abstract: Consuming water with increased hydrogen content can provide clinical benefits to humans and animals through a non-mitochondria alternative cellular energy (ACE) pathway and also as an antioxidant. This application discloses that the hydrogen content of drinking water can be safely increased by placing into the water a hydrogen generating device, such as a mixture of metallic magnesium and magnesium chloride containing solution, whereby the device allows for the selective passage of the generated hydrogen but restricts the passage of magnesium and magnesium ions. This partitioning of hydrogen from magnesium ions is achieved by using either reverse osmosis membrane or low density plastic material such as polyvinylidene chloride (PVDC or Saran), to create a sealed container of the magnesium and magnesium chloride, that can be placed into drinkable water. The magnesium chloride can be initially placed into a breakable inner compartment within the hydrogen permeable container.
    Type: Application
    Filed: July 9, 2008
    Publication date: January 14, 2010
    Inventor: William John Martin
  • Publication number: 20090280193
    Abstract: Alternative cellular energy pigments (ACE-pigments) provide a source of cellular energy other than that provided through the oxidative metabolism of foods, or in the case of plants and certain bacteria, through the process of photosynthesis. In some patients, ACE pigments exist in a form that can be further energized or activated using ultraviolet (UV) light, especially if the reaction is initially triggered by the presence of suitable dyes, such as neutral red. A method is described to further enhance the activation of the ACE pathway in humans and animals deprived of ACE. The method comprises using natural or man-made sources of ACE products (enerceuticals), with or without the inclusion of a suitable dye, such as neutral red; or other activating components, such as magnesium chloride; with the combined mixture being put into a UV transparent container, such as a plastic bag, or placed on some other material, which can be laid onto the skin and illuminated with a UV light source.
    Type: Application
    Filed: May 8, 2008
    Publication date: November 12, 2009
    Applicant: MI Hope Inc.
    Inventor: William John Martin
  • Publication number: 20090202442
    Abstract: Alternative cellular energy pigments (ACE-pigments) provide a source of cellular energy other than that provided through the oxidative metabolism of foods, or in the case of plants and certain bacteria, through the process of photosynthesis. In some patients, ACE pigments exist in a form that can be further energized or activated using ultraviolet (UV) light, especially if the reaction is initially triggered by the presence of suitable dyes, such as neutral red. A method is described to further enhance the activation of the ACE pathway in humans and animals deprived of ACE. The method comprises using natural or man-made sources of ACE products (enerceuticals), with or without the inclusion of a suitable dye, such as neutral red; and applying the material(s) to the skin, either directly or separated by an impermeable barrier; and illuminating the enerceutical with a UV light source.
    Type: Application
    Filed: February 11, 2008
    Publication date: August 13, 2009
    Inventor: William John Martin
  • Publication number: 20090181467
    Abstract: Alternative cellular energy pigments (ACE-pigments) provide a source of cellular energy other than that provided through the oxidative metabolism of foods, or in the case of plants and certain bacteria, through the process of photosynthesis. In some patients, ACE pigments exist in a form that can be further energized or activated using ultraviolet (UV) light, especially if the reaction is initially triggered by the presence of suitable dyes, such as neutral red. A method is described to assess the energy status of the ACE pathway in an individual or animal and also a method that involves the use of UV light in conjunction with a suitable dye, for activating the pathway in those individuals or animals in which the pathway is not fully charged. Kits for these purposes are also described.
    Type: Application
    Filed: January 16, 2008
    Publication date: July 16, 2009
    Applicant: MI Hope Inc. dba Progressive University
    Inventor: William John Martin
  • Publication number: 20090163831
    Abstract: Ultraviolet light reactive alternative cellular energy pigments (ACE-pigments) are produced in response to certain types of viral infections, and in other pathological circumstances. ACE-pigments have energy transducing activities, and in particular have the capacity to convert various forms of physical energies, such as electromagnetic radiations, magnetic force and sound frequencies, into chemical energy (both reducing and oxidizing). They are thought to play a metabolic supportive role in the virus infected cells. ACE-pigments can be eliminated from the body through the skin and can also be found in and attached to hair. A method is described for collecting ACE-pigments from the skin and bodily fluids of a patient and viewing the ACE pigments using ultraviolet light in the presence of a dye such as neutral red, which enhances their ultraviolet (UV) induced fluorescence.
    Type: Application
    Filed: December 24, 2007
    Publication date: June 25, 2009
    Applicant: MI Hope Inc. dba Progressive University
    Inventor: William John Martin
  • Publication number: 20090148540
    Abstract: An electrolysis method is described for generating an aqueous solution of copper citrate that has bacteriocidal activity against methicillin resistant Staphylococcus aureus (MRSA) bacteria. Gram positive bacteria are known to be relatively more sensitive to the bacteriocidal activities of copper ions than are Gram negative bacteria. Situations exist in which a disinfectant that is relatively more toxic for Gram positive bacteria will be advantageous over a more broadly active disinfectant, such as that provided by most other disinfectants. In particular, a disinfectant that is relatively selective for Gram positive bacteria could help preserve various non-pathogenic Gram negative microbial populations. The residual Gram negative bacteria can potentially compete with, and thereby lessen the chances of the reintroduction of pathogenic Gram positive bacteria, such as MRSA, Streptococcus, Clostridium difficile and Listeria monocytogenes.
    Type: Application
    Filed: December 10, 2007
    Publication date: June 11, 2009
    Applicant: MI HOPE INCORPORATED
    Inventors: William John Martin, Stephen Benet Palmer
  • Publication number: 20040009467
    Abstract: Mineral-containing, auto-fluorescent, pigmented materials are disclosed that comprise conglomerates or aggregates of very fine chemical structures that are held together by a newly defined force termed Selective Mineral Affinity Force (SMAF). Particles comprising these materials can form on the skin of some stealth virus infected patients. They can also be seen attached to the hair strands of such patients. Similar particles form in stealth virus cultures and are thought to provide an alternative (non-mitochondria) cellular energy source for the virally infected cells, including the conversion of electromagnetic energy into chemical energy. These particles have been called alternative cellular energy (ACE)-pigments. The patient skin and hair derived aggregated ACE-pigments can be disrupted into highly energetic smaller components using various chemicals, including aldehydes and alcohols.
    Type: Application
    Filed: July 10, 2002
    Publication date: January 15, 2004
    Inventor: William John Martin
  • Publication number: 20030138922
    Abstract: A method of causing irreversible damage to stealth virus infected cells, based on exposing the infected cells to magnetic energy. The method of the present application specifically relates to the culturing of stealth viruses from an infected subject and determining the presence of magnetic and/or paramagnetic material in the stealth virus infected culture. Magnetic and/or paramagnetic material can also be found in cultures of bacteria that are infected with the patient's stealth virus. The cultured stealth virus infected cells are tested for susceptibility to cell damage caused by a magnetic field that is not significantly injurious to normal uninfected cells. The presence of magnetic and/or paramagnetic material in the stealth virus culture and the demonstration that exposure to a strong magnetic field can cause damage to stealth virus infected cells, form the basis of therapy for stealth virus infected patients and animals.
    Type: Application
    Filed: January 24, 2002
    Publication date: July 24, 2003
    Inventor: William John Martin
  • Publication number: 20030129583
    Abstract: A method of causing irreversible damage to stealth virus infected cells, based on light induced toxic photosensitivity of abnormal, aggregated, intracellular materials present in the infected cells. The method of the present application specifically relates to the culturing of stealth viruses from an infected subject and determining the presence in the stealth virus infected culture of auto-fluorescent material. Auto-fluorescent material can also be found in cultures of bacteria that are infected with the patient's stealth virus. The cultured stealth virus infected cells are to be further tested for susceptibility to the cellular destructive effect of light therapy given at various wavelengths that are not injurious to normal uninfected cells. The presence of auto-fluorescent material in the stealth virus culture and the demonstration that exposure to light can cause damage to stealth virus infected cells, form the basis of therapy for stealth virus infected patients and animals.
    Type: Application
    Filed: January 8, 2002
    Publication date: July 10, 2003
    Inventor: William John Martin
  • Patent number: 6519206
    Abstract: A sonic device, adapted to be carried by a predatory animal is provided. The device emits a sonic signal either continuously or intermittently with a predetermined interval and duration. The device is controlled by a microprocessor (2) which is programmable to emit appropriate signals. The device may be temporarily deactivated by a location switch (12) when the predatory animal enters a defined location, such as a domestic environment, or by an optical switch when the ambient light intensity falls below a particular threshold level. The device includes a waterproof housing and a battery power source and may also include one or more solar panels.
    Type: Grant
    Filed: March 27, 2001
    Date of Patent: February 11, 2003
    Inventors: William John Martin, Vincent Lynch, Harold Convey
  • Patent number: 5985546
    Abstract: A method of detecting a stealth virus is provided by culturing a sample under conditions in which any stealth virus in the sample is able to induce a cytopathic effect. A method for culturing a virus is also provided by (a) cocentrifuging a sample of said virus with a permissive cell line of indicator cells; (b) inoculating the cell mixture into culture vessels; (c) adding viral enhancing medium to the culture; and (d) detecting in vitro a cytopathic effect in the permissive cell line.
    Type: Grant
    Filed: May 26, 1998
    Date of Patent: November 16, 1999
    Inventor: William John Martin